Clinical Trial

Pathogen-microbiome Interaction During Helicobacter Pylori Infection

Study acronym: PREDICTHP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Helicobacter pylori affects the gut microbiome in ways that are only partially understood. In which patients H. pylori causes severe disease and in whom it merely colonizes, possibly even with beneficial effects, is not understood. The investigators are pursuing the hypothesis that changes in the gut microbiome that can be easily measured in stool have such predictive value.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-11-09; most recent amendment 2024-12-04.
Status change: Not Yet Recruiting → Recruiting 2022-05-17
Trial Details
NCT Number NCT05121025
Lead Sponsor University Hospital Freiburg
Conditions Helicobacter Pylori Infection
Enrollment 180 participants
Start Date 2022-03-11
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-05